BAT Group is a London-based corporate venture capital investor associated with British American Tobacco, investing through Btomorrow Ventures with a 350m commitment across two funds. It backs early-stage companies globally in reduced-risk nicotine products, functional drinks and snacks, technology and emerging capabilities, impact and sustainability, and has acted as a lead investor in a later-stage cannabis/pharmaceutical and consumer products financing in Germany.